Standing Ovation, a Paris-based biotech, has raised €25M ($28.5M) in Series B funding led by Bpifrance, with Bel Group, Danone Ventures, and others participating. The round includes €5M in non-dilutive funding, bringing total new capital to €30M. Standing Ovation produces Advanced Casein™, a precision-fermented protein identical to animal casein in structure, taste, and functionality but using dairy by-products like whey permeate. The funds will scale industrial production, pursue FDA GRAS approval by end-2026 for US launch, and expand R&D.
French Dairy Fermentation Funding Surges
The raise follows Verley's €32M ($38M) Series A in February 2026 for precision-fermented whey proteins. This €57M combined in two months signals resurgent investor confidence in French precision fermentation for dairy alternatives after a funding slowdown. Standing Ovation differentiates with its circular model upcycling whey waste, validated at industrial scale with Bel Group last fall. Such partnerships position it ahead of US peers like Perfect Day, which has raised $770M focused on whey.
Whey Waste Burdens Dairy Industry
Global cheese production turns 80-90% of input milk into underutilized whey, creating disposal challenges and environmental strain. Traditional casein production demands high land, water, and CO2 emissions. Dairy faces methane scrutiny and supply risks from climate change. Current alternatives lack casein's functional properties for cheese melting or yogurt texture.
Circular Fermentation Unlocks Casein
Standing Ovation engineers microbes to ferment casein from dairy co-products like acid whey, avoiding food sugars. This yields lactose-free, antibiotic-free protein with full traceability and patented processes across eight families. Unlike Perfect Day's whey emphasis or Remilk's full milk proteins, it targets casein (80% of milk protein) for cheese and high-protein apps. Lifecycle analysis shows 74% lower GHG, 68% less water, and 99% less land versus animal casein.
As co-founder Romain Chayot explained:
“We value the work of farmers, we implement a circular economy, we reduce our production costs.”
Strategic Backers Fuel Scale-Up
Bpifrance's France 2030 investment underscores government support for food sovereignty. Corporate investors Bel Group (industrial trials partner) and Danone Ventures provide validation and ecosystem access. Others like Astanor, Seventure Partners signal conviction in sustainable ingredients. This mix blends mission-driven and growth capital for global expansion.
Precision Fermentation Market Explodes
The precision fermentation market stands at $6.14B in 2026, projected to reach $113.86B by 2034 at 44% CAGR per Fortune Business Insights. Dairy proteins segment hits $4.53B this year. Trends favor functional proteins amid vegan demand and emissions pressure. EU regulatory tailwinds like the Biotech Act ease paths, though EFSA approvals lag.
Fermentation Experts Lead Team
Co-founder Romain Chayot brings 15 years heading metabolic engineering at Global Bioenergies, directly applicable to precision fermentation. New CEO Yvan Chardonnens scaled €1.3B food sales at Roquette and led Oterra post-merger. The team includes ex-Danone, Solvay, and Lactalis experts, balancing deep biotech with commercial scaling prowess.
US Launch Targets 2026
Standing Ovation plans FDA GRAS 'no questions' letter by end-2026 for US commercialization, followed by EU/Asia in 2027. Cost parity arrives at 2,000 tons annual production via asset-light partners like Ajinomoto and Tetra Pak. Current output nears 1 tonne/year, with hybrid dairy products first. Partnerships with CMOS in Eastern Europe and India support global ramp.
As CEO Yvan Chardonnens noted:
“This is not a concept. This is something we demonstrated at scale with the Bel Group last fall.”